Sequential inhibitory effects of antitumor agents related to levodopa and dopamine upon DNA synthetic enzymes
- 1 January 1986
- journal article
- research article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 35 (2) , 271-275
- https://doi.org/10.1016/0006-2952(86)90525-3
Abstract
No abstract availableThis publication has 14 references indexed in Scilit:
- Inhibition of ribonucleotide reductase by antitumor agents related to levodopa and dopamineBiochemical Pharmacology, 1985
- Inhibitor evidence for allosteric interaction in the replitase multienzyme complexNature, 1983
- 3,4-Dihydroxybenzylamine: An Improved Dopamine Analog Cytotoxic for Melanoma Cells in Part Through Oxidation Products Inhibitory to DNA PolymeraseJournal of Investigative Dermatology, 1983
- Regulation of thymidylate synthetase in mouse leukemia cells (L1210).Journal of Biological Chemistry, 1980
- A permeable animal cell preparation for studying macromolecular synthesis. DNA synthesis and the role of deoxyribonucleotides in S phase initiationBiochemistry, 1978
- Incorporation of 3H-uridine and 3H-uracil into RNA: A simple technique for the detection of mycoplasma contamination of cultured cellsExperimental Cell Research, 1974
- The response in vitro, of continuous cultures of human lymphoblasts (CCRF-CEM cells) to chemotherapeutic agentsBiochemical Pharmacology, 1967
- An Isotopic Assay for Thymidylate Synthetase*Biochemistry, 1966